Humacyte Growth Metrics (2024-2025) | HUMA

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 0.67%0.37%-20.26%-15.60%
Assets (QoQ) (Quarter) -14.36%-17.01%20.14%17.90%-14.62%-34.07%27.16%
Capital Expenditures Growth (1y) (Quarter) 1,779.31%-54.03%-94.75%-38.10%
Capital Expenditures (QoQ) (Quarter) 1,782.76%71.06%-93.25%765.08%-53.94%-80.48%-20.41%
Cash & Equivalents Growth (1y) (Quarter) -45.63%-59.37%-5.26%12.38%
Cash & Equivalents (QoQ) (Quarter) -18.96%-78.02%118.45%39.75%-39.44%-48.76%159.13%
Cash from Investing Activities Growth (1y) (Quarter) 41.69%-208.70%94.75%38.10%
Cash from Investing Activities (QoQ) (Quarter) 52.94%-407.61%93.25%-261.90%-149.12%91.37%20.41%
Cash from Operations Growth (1y) (Quarter) -4.58%-24.00%-4.33%1.79%
Cash from Operations (QoQ) (Quarter) 22.15%-7.59%-16.02%-7.61%7.69%9.47%-9.21%
EBITDA Margin (QoQ) (Quarter) -2.01M1.02M-0.43M
EBIT Growth (1y) (Quarter) 12.84%-0.77%19.33%-9.64%
EBIT Margin (QoQ) (Quarter) -0.54M0.66M-0.34M
EBIT (QoQ) (Quarter) -10.90%-2.49%7.09%17.47%-28.22%17.95%-26.28%
EBT Growth (1y) (Quarter) 6.80%-2.40%16.84%-12.25%
EBT Margin (QoQ) (Quarter) -0.55M0.69M-0.36M
EBT (QoQ) (Quarter) -12.12%-3.44%6.34%14.20%-23.19%15.99%-26.42%
Enterprise Value Growth (1y) (Quarter) 45.63%59.37%5.26%-12.38%
Enterprise Value (QoQ) (Quarter) 18.96%78.02%-118.45%-39.75%39.44%48.76%-159.13%
EPS (Basic) Growth (1y) (Quarter) 196.55%50.00%66.67%6.25%
EPS (Basic) (QoQ) (Quarter) -65.52%31.25%51.52%275.00%-185.71%54.17%-36.36%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) 196.55%50.00%66.67%6.25%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -65.52%31.25%51.52%275.00%-185.71%54.17%-36.36%
FCF Margin (QoQ) (Quarter) -0.32M0.57M-0.24M
Free Cash Flow Growth (1y) (Quarter) -6.46%-22.05%-0.45%1.88%
Free Cash Flow (QoQ) (Quarter) 20.23%-9.18%-11.74%-9.40%8.56%10.14%-9.14%
Gross Margin (QoQ) (Quarter) -0.00M0.00M-0.19M
Gross Profit (QoQ) (Quarter) -76.22%460.23%-1,847.46%
Interest Coverage Ratio Growth (1y) (Quarter) 47.24%0.41%24.70%11.09%
Interest Coverage Ratio (QoQ) (Quarter) 19.92%-5.73%9.68%31.00%-51.15%20.06%-6.64%
Net Cash Flow Growth (1y) (Quarter) -48.91%-13.03%-198.10%27.36%
Net Cash Flow (QoQ) (Quarter) -162.59%-4.79%205.98%-26.49%-238.47%-176.35%145.28%
Net Income Growth (1y) (Quarter) 6.80%-2.40%16.84%-12.25%
Net Income (QoQ) (Quarter) -12.12%-3.44%6.34%14.20%-23.19%15.99%-26.42%
Net Income towards Common Stockholders Growth (1y) (Quarter) 6.80%-2.40%16.84%-12.25%
Net Income towards Common Stockholders (QoQ) (Quarter) -12.12%-3.44%6.34%14.20%-23.19%15.99%-26.42%
Net Margin (QoQ) (Quarter) -0.55M0.69M-0.36M
Operating Income Growth (1y) (Quarter) 12.84%-0.77%19.33%-9.64%
Operating Income (QoQ) (Quarter) -10.90%-2.49%7.09%17.47%-28.22%17.95%-26.28%
Operating Margin (QoQ) (Quarter) -0.54M0.66M-0.34M
Profit After Tax Growth (1y) (Quarter) 222.71%33.54%55.33%-18.45%
Profit After Tax (QoQ) (Quarter) -77.65%30.82%46.58%286.91%-196.22%53.50%-41.66%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -12.54%-14.62%-18.12%-19.59%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -3.25%-2.30%-4.89%-2.72%-5.55%-6.30%-6.61%
Return on Assets Growth (1y) (Quarter) -18.00
Return on Assets (QoQ) (Quarter) 16.000.00M-20.00-14.00
Return on Capital Employed Growth (1y) (Quarter) -19.00
Return on Capital Employed (QoQ) (Quarter) 22.00-1.00-32.00-9.00
Return on Equity Growth (1y) (Quarter) 0.01M
Return on Equity (QoQ) (Quarter) 0.00M-0.00M0.03M-0.02M
Return on Sales (QoQ) (Quarter) -0.01M0.01M-0.00M
Revenue (QoQ) (Quarter) -41.78%150.17%-37.98%
Share-based Compensation Growth (1y) (Quarter) 71.05%69.38%61.73%84.65%
Share-based Compensation (QoQ) (Quarter) -1.17%8.00%9.15%46.81%-2.13%3.12%24.62%
Shareholder's Equity Growth (1y) (Quarter) 37.82%114.32%92.54%105.90%
Shareholder's Equity (QoQ) (Quarter) -208.16%-125.27%17.34%168.43%-88.76%-217.25%165.44%
Total Debt Growth (1y) (Quarter) 14.50%14.09%-66.60%
Total Debt (QoQ) (Quarter) 3.66%3.39%4.78%1.96%3.28%-69.73%